Zhou Shengyu

Professional Biography

Dr. Zhou Shengyu is Chief Physician in Medical Oncology at Cancer Hospital, CAMS, Beijing. Zhou serves as Chairman. Clinical expertise includes Hodgkin lymphoma — chemotherapy, targeted therapy (brentuximab vedotin), and immunotherapy combinations, Diffuse large B-cell lymphoma (DLBCL) — first-line and salvage systemic therapy, biomarker-driven treatment selection, Indolent non-Hodgkin lymphoma — low-dose radiotherapy protocols, systemic therapy, and watch-and-wait strategies, Head and neck squamous cell carcinoma (HNSCC) — systemic therapy, immunotherapy-radiotherapy combinations for recurrent/metastatic disease. Lead investigator at CAMS Cancer Hospital in the CLCG-iNHL-01 multicenter phase II trial of moderate low-dose radiotherapy for indolent non-Hodgkin lymphoma — establishing a well-tolerated, effective radiotherapy dosing standard for iNHL management (Future Oncol 2024, PMID 38179936). Chief Physician at the National Cancer Center / CAMS Cancer Hospital — China's most selective national cancer institution; 30+ years of clinical experience in tumor internal medicine spanning lymphoma, head and neck cancer, and lung cancer.